EUVIMEDEUVIMED entdecken
Crossref

Spray dried plasma manufactured from apheresis and whole blood derived plasma

Lucy Bower, Sian Huish iD, Katarzyna Oleniacz, Matthew Ellington, Melanie J Robbins iD, Tom Woolley, Jihae Sohn, Laura Green, Rebecca Cardigan

Transfusion · 2026-11 · 66 (11) · 2348-2359

DOI: 10.1111/trf.70219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, online erschienen am 01.07.2026. Verfasst von Lucy Bower und 8 weiteren Autor:innen. Beteiligte Einrichtung: Component Development Laboratory, NHS Blood and Transplant, Cambridge, UK. Hauptthemen laut MEDLINE: Plasma, Blood Component Removal, Blood Preservation, Spray Drying. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Ministry of Defence.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dried plasma is an attractive option when provision of frozen plasma is challenging. FrontlineODP™ system (Velico Medical) is a spray drying system producing a unit of spray dried plasma (SDP), in a blood bag, in around 30 min. This study evaluates coagulation parameters before and after drying, using two types of starting plasma: Whole blood (WB) derived, and apheresis derived.

Methods

A minimum of 15 units each of WB derived CPD‐anticoagulated plasma and plasmapheresis (Aurora, Fresenius Kabi) sodium citrate‐anticoagulated plasma were sampled and frozen within 12–18 h of venepuncture. Units were spray dried using the Velico FrontlineODP™ system. Following rehydration with sterile water, further samples were taken. All samples (pre drying, immediately post rehydration and 6 h post rehydration) were tested in parallel for a range of coagulation parameters, including thrombin generation, as well as biochemical parameters and bacterial contamination.

Results

All dried plasma units rehydrated in an average of 6 min. All coagulation parameters were within ±20% pre to post drying, except von Willebrand factor (vWF) activity and FXIII activity, which decreased by approximately 50% and 25%, respectively. Further investigation of vWF showed a change in the ratio of high and low molecular weight multimers. No bacterial contamination was detected in any of the units. Summary/Conclusions The FrontlineODP system can be incorporated into a standard blood service laboratory environment and successfully produce SDP with acceptable levels of coagulation proteins. Clinical data assessing SDP in a relevant patient population are now needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlasmaBlood Component RemovalBlood PreservationSpray DryingHumansPlasmapheresisDesiccationBlood Coagulation

Stichwörter der Autor:innen

FFPcoagulationdried plasmaplasmaspray dried plasma

Autor:innen und Institutionen

  • Component Development Laboratory, NHS Blood and Transplant, Cambridge, UK.
  • Department of Haematology, University of Cambridge, Cambridge, UK.
  • Academic Department of Military Emergency Medicine, Royal Centre for Defence Medicine, Birmingham, UK.
  • Academic Department of Military Anaesthesia and Critical Care, Research & Clinical Innovation, Birmingham, UK.
  • Velico Medical, Beverly, Massachusetts, USA.
  • Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, London, UK.

ORCID-Profile: Sian Huish, Melanie J Robbins

Förderung

  • Ministry of Defence

Zitieren

APA

Bower, L., Huish, S., Oleniacz, K., Ellington, M., Robbins, M. J., Woolley, T., Sohn, J., Green, L., & Cardigan, R. (2026). Spray dried plasma manufactured from apheresis and whole blood derived plasma. Transfusion, 66(11), 2348-2359. https://doi.org/10.1111/trf.70219

Vancouver

Bower L, Huish S, Oleniacz K, Ellington M, Robbins MJ, Woolley T, et al. Spray dried plasma manufactured from apheresis and whole blood derived plasma. Transfusion. 2026;66(11):2348-2359. doi:10.1111/trf.70219

BibTeX
@article{Bower2026,
  author = {Bower, Lucy and Huish, Sian and Oleniacz, Katarzyna and Ellington, Matthew and Robbins, Melanie J and Woolley, Tom and Sohn, Jihae and Green, Laura and Cardigan, Rebecca},
  title = {Spray dried plasma manufactured from apheresis and whole blood derived plasma},
  journal = {Transfusion},
  year = {2026},
  volume = {66},
  number = {11},
  pages = {2348--2359},
  doi = {10.1111/trf.70219}
}
Kostenlos starten →